| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.966 | 0.004 | 0.988 | Analgesic | 0.988 0.003 DB00295 | DB00295 | |
| 0.946 | 0.002 | 0.97 | Psychostimulant | 0.97 0.002 DB00295 | DB00295 | |
| 0.917 | 0.003 | 0.917 | Spasmolytic | 0.858 0.004 DB00295 | ||
| 0.893 | 0.002 | 0.975 | Analgesic, opioid | 0.975 0.001 DB00295 | DB00295 | |
| 0.826 | 0.002 | 0.881 | Anesthetic general | 0.881 0.002 DB00295 | DB00295 | |
| 0.805 | 0.002 | 0.87 | Opioid antagonist | 0.87 0.001 DB00295 | DB00295 | |
| 0.778 | 0.002 | 0.858 | Opioid mu receptor antagonist | 0.858 0.001 DB00295 | DB00295 | |
| 0.768 | 0.002 | 0.877 | Opioid agonist | 0.877 0.002 DB00295 | DB00295 | |
| 0.737 | 0.002 | 0.798 | Opioid delta receptor antagonist | 0.798 0.001 DB00295 | DB00295 | |
| 0.716 | 0.002 | 0.857 | Opioid mu receptor agonist | 0.857 0.001 DB00295 | DB00295 | |
| 0.706 | 0.002 | 0.778 | Opioid kappa receptor antagonist | 0.778 0.001 DB00295 | DB00295 | |
| 0.625 | 0.004 | 0.625 | Alpha 2 adrenoreceptor antagonist | 0.618 0.004 DB00295 | ||
| 0.618 | 0.003 | 0.77 | Opioid delta receptor agonist | 0.77 0.002 DB00295 | DB00295 | |
| 0.588 | 0.003 | 0.698 | Alpha 2a adrenoreceptor antagonist | 0.698 0.003 DB00295 | DB00295 | |
| 0.584 | 0.004 | 0.725 | Sigma receptor antagonist | 0.725 0.003 DB00295 | DB00295 | |
| 0.549 | 0.006 | 0.553 | Sigma receptor agonist | 0.553 0.005 DB00295 | DB00295 | |
| 0.513 | 0.002 | 0.659 | Opioid kappa receptor agonist | 0.659 0.001 DB00295 | DB00295 | |
| 0.522 | 0.024 | 0.733 | 5 Hydroxytryptamine release stimulant | 0.733 0.005 DB00295 | DB00295 | |
| 0.444 | 0.008 | 0.444 | Alpha adrenoreceptor antagonist | 0.277 0.017 DB00295 | ||
| 0.408 | 0.015 | 0.408 | P-glycoprotein inhibitor | 0.382 0.018 DB00295 | ||
| 0.432 | 0.057 | 0.622 | Transcription factor NF kappa B inhibitor | 0.622 0.029 DB00295 | DB00295 | |
| 0.428 | 0.054 | 0.491 | Immunosuppressant | 0.491 0.036 DB00295 | DB00295 | |
| 0.321 | 0.005 | 0.321 | Toll-Like receptor antagonist | 0.283 0.009 DB00295 | ||
| 0.428 | 0.123 | 0.486 | Antiinflammatory | 0.486 0.093 DB00295 | DB00295 | |
| 0.317 | 0.012 | 0.356 | Antipruritic | 0.356 0.009 DB00295 | DB00295 | |
| 0.344 | 0.047 | 0.417 | Hypoxia-inducible factor 1 alpha inhibitor | 0.417 0.026 DB00295 | DB00295 | |
| 0.299 | 0.015 | 0.319 | Interleukin 6 antagonist | 0.319 0.013 DB00295 | DB00295 | |
| 0.238 | 0.004 | 0.327 | Toll-Like receptor 4 antagonist | 0.327 0.003 DB00295 | DB00295 | |
| 0.236 | 0.015 | 0.236 | Dopamine antagonist | 0.157 0.024 DB00295 | ||
| 0.228 | 0.008 | 0.228 | Dopamine agonist | 0.214 0.009 DB00295 | ||
| 0.281 | 0.061 | 0.281 | Tumour necrosis factor alpha release inhibitor | 0.217 0.095 DB00295 | ||
| 0.229 | 0.014 | 0.229 | Dopamine D2 antagonist | 0.164 0.021 DB00295 | ||
| 0.233 | 0.03 | 0.302 | Acetylcholine M1 receptor antagonist | 0.302 0.014 DB00295 | DB00295 | |
| 0.253 | 0.051 | 0.323 | Nitric oxide antagonist | 0.323 0.036 DB00295 | DB00295 | |
| 0.216 | 0.017 | 0.351 | Expectorant | 0.351 0.006 DB00295 | DB00295 | |
| 0.195 | 0.005 | 0.195 | Dopamine D2 agonist | 0.182 0.005 DB00295 | ||
| 0.202 | 0.018 | 0.202 | Alpha 2c adrenoreceptor antagonist | 0.131 0.042 DB00295 | ||
| 0.221 | 0.038 | 0.221 | Cholinergic | 0.212 0.041 DB00295 | ||
| 0.332 | 0.151 | 0.388 | Apoptosis agonist | 0.388 0.12 DB00295 | DB00295 | |
| 0.205 | 0.023 | 0.205 | Antiadrenergic | 0.148 0.036 DB00295 | ||
| 0.283 | 0.106 | 0.283 | Vasodilator, peripheral | 0.257 0.122 DB00295 | ||
| 0.191 | 0.025 | 0.191 | Adrenaline antagonist | 0.129 0.041 DB00295 | ||
| 0.274 | 0.111 | 0.274 | Vasodilator, coronary | |||
| 0.173 | 0.014 | 0.202 | Prolactin inhibitor | 0.202 0.008 DB00295 | DB00295 | |
| 0.191 | 0.034 | 0.23 | Cholinergic antagonist | 0.23 0.025 DB00295 | DB00295 | |
| 0.177 | 0.038 | 0.217 | Acetylcholine antagonist | 0.217 0.027 DB00295 | DB00295 | |
| 0.167 | 0.045 | 0.167 | Acetylcholinesterase inhibitor | 0.155 0.052 DB00295 | ||
| 0.122 | 0.008 | 0.123 | Dopamine D5 antagonist | 0.123 0.008 DB00295 | DB00295 | |
| 0.111 | 0.004 | 0.132 | Prolactin release inhibitor | 0.132 0.003 DB00295 | DB00295 | |
| 0.137 | 0.031 | 0.187 | Antineoplastic alkaloid | 0.187 0.017 DB00295 | DB00295 | |
| 0.181 | 0.079 | 0.207 | Hepatoprotectant | 0.207 0.061 DB00295 | DB00295 | |
| 0.135 | 0.032 | 0.135 | Estrogen antagonist | 0.115 0.064 DB00295 | ||
| 0.144 | 0.047 | 0.165 | Acetylcholine muscarinic antagonist | 0.165 0.036 DB00295 | DB00295 | |
| 0.123 | 0.029 | 0.123 | Estrogen receptor beta antagonist | 0.104 0.057 DB00295 | ||
| 0.226 | 0.135 | 0.272 | Caspase 3 stimulant | 0.272 0.095 DB00295 | DB00295 | |
| 0.112 | 0.031 | 0.117 | Alpha 2d adrenoreceptor antagonist | 0.117 0.026 DB00295 | DB00295 | |
| 0.102 | 0.024 | 0.139 | Dopamine D1 antagonist | 0.139 0.016 DB00295 | DB00295 | |
| 0.096 | 0.045 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.098 0.042 DB00295 | DB00295 | |
| 0.094 | 0.043 | 0.144 | Acetylcholine nicotinic antagonist | 0.144 0.022 DB00295 | DB00295 | |
| 0.05 | 0.014 | 0.097 | Nociceptin (N/OFQ) receptor antagonist | 0.097 0.006 DB00295 | DB00295 | |
| 0.052 | 0.018 | 0.052 | Dopamine D3 agonist | |||
| 0.173 | 0.139 | 0.28 | Antioxidant | 0.28 0.07 DB00295 | DB00295 | |
| 0.106 | 0.077 | 0.106 | Anesthetic local | |||
| 0.08 | 0.057 | 0.138 | Antineoplastic antibiotic | 0.138 0.034 DB00295 | DB00295 | |
| 0.095 | 0.073 | 0.095 | Nav1.1 sodium channel blocker | 0.088 0.083 DB00295 | ||
| 0.091 | 0.071 | 0.091 | Interleukin 12 antagonist | |||
| 0.026 | 0.012 | 0.051 | Dopamine D1 agonist | 0.051 0.005 DB00295 | DB00295 | |
| 0.053 | 0.045 | 0.053 | Dopamine uptake inhibitor | 0.053 0.046 DB00295 | ||
| 0.071 | 0.064 | 0.071 | Estrogen receptor alpha antagonist | |||
| 0.045 | 0.045 | 0.054 | Nicotinic receptor alpha4 subunit antagonist | 0.054 0.027 DB00295 | DB00295 | |
| 0.011 | 0.02 | 0.03 | NMDA receptor phencyclidine site antagonist | 0.03 0.004 DB00295 | DB00295 | |
| 0.075 | 0.09 | 0.098 | Breast cancer-resistant protein inhibitor | 0.098 0.057 DB00295 | DB00295 | |
| 0.061 | 0.077 | 0.089 | Glycine receptor agonist | 0.089 0.028 DB00295 | DB00295 | |
| 0.051 | 0.068 | 0.1 | Neuronal nicotinic receptor antagonist | 0.1 0.024 DB00295 | DB00295 | |
| 0.01 | 0.032 | 0.029 | Nociceptin (N/OFQ) receptor agonist | 0.029 0.01 DB00295 | DB00295 | |
| 0.125 | 0.151 | 0.155 | Lipocortins synthesis antagonist | 0.155 0.098 DB00295 | DB00295 | |
| 0.07 | 0.107 | 0.097 | Creatine kinase inhibitor | 0.097 0.062 DB00295 | DB00295 | |
| 0.076 | 0.12 | 0.125 | MAO inhibitor | 0.125 0.072 DB00295 | DB00295 | |
| 0.021 | 0.07 | 0.033 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.031 DB00295 | DB00295 | |
| 0.078 | 0.147 | 0.115 | Electron transport complex I inhibitor | 0.115 0.054 DB00295 | DB00295 | |
| 0.098 | 0.168 | 0.135 | NOS3 expression enhancer | 0.135 0.09 DB00295 | DB00295 | |
| 0.086 | 0.16 | 0.213 | Protein kinase stimulant | 0.213 0.037 DB00295 | DB00295 | |
| 0.14 | 0.225 | 0.183 | Peptidyltransferase inhibitor | 0.183 0.123 DB00295 | DB00295 | |
| 0.059 | 0.165 | 0.123 | Adenylate cyclase inhibitor | 0.123 0.065 DB00295 | DB00295 | |
| 0.115 | 0.224 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.142 0.065 DB00295 | DB00295 | |
| 0.099 | 0.222 | 0.195 | Immunostimulant | 0.195 0.123 DB00295 | DB00295 | |
| 0.061 | 0.196 | 0.114 | Lipid peroxidase inhibitor | 0.114 0.1 DB00295 | DB00295 | |
| 0.096 | 0.235 | 0.196 | Free radical scavenger | 0.196 0.101 DB00295 | DB00295 | |
| 0.018 | 0.195 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.042 DB00295 | DB00295 | |
| 0.097 | 0.287 | 0.165 | DNA damaging | 0.165 0.151 DB00295 | DB00295 | |
| 0.042 | 0.234 | 0.088 | Anabolic | 0.088 0.083 DB00295 | DB00295 | |
| 0.13 | 0.325 | 0.2 | Tyrosine 3 hydroxylase inhibitor | 0.2 0.136 DB00295 | DB00295 | |
| 0.125 | 0.32 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 DB00295 | DB00295 | |
| 0.135 | 0.353 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.288 0.052 DB00295 | DB00295 | |
| 0.062 | 0.357 | 0.138 | Melanin inhibitor | 0.138 0.1 DB00295 | DB00295 | |
| 0.027 | 0.34 | 0.106 | Cystathionine beta-synthase inhibitor | 0.106 0.07 DB00295 | DB00295 | |
| 0.021 | 0.34 | 0.075 | Glycine receptor antagonist | 0.075 0.065 DB00295 | DB00295 | |
| 0.044 | 0.434 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.067 DB00295 | DB00295 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |